hristosbilis.ai
Tracker / Company

Genmab

4 entries Most recent disclosure: Last verified:

AI drug discovery

Data science and AI for target and biomarker discovery

Deployment

Genmab says it has expanded its scientific focus to use data science and AI to aid in the discovery of new targets and biomarkers and to bolster its precision medicine and translational laboratory capabilities.

Company Archive pending Verified: Permalink

Clinical development

Agentic AI partnership with Anthropic for clinical development

Announcement

Genmab announced a partnership with Anthropic. Under the agreement, the companies will design and deploy custom, Claude-powered agentic AI solutions to support Genmab's clinical development priorities.

Partners: Anthropic

Company Archive pending Verified: Permalink

Enterprise, IT and knowledge work

AI Everywhere partnership for ChatGPT access

Deployment

Genmab's 2024 annual report describes a partnership with ChatGPT to launch AI Everywhere, so that more than 2,000 colleagues can use ChatGPT.

more than 2,000 colleagues company-reported

Partners: ChatGPT

Company Archive pending Verified: Permalink

Other

Postdoctoral program using AI and machine learning

Deployment

Genmab's 2023 corporate responsibility report says it launched a postdoctoral program, its first. The program backs projects that use AI and machine learning tools for digital pathology, single-cell genomics on patient samples, and mathematical modeling of antibody products.

Company Archive pending Verified: Permalink